Description |
glycogen phosphorylase, muscle associated |
endoplasmic reticulum oxidoreductase 1 beta |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Pyridoxal phosphate
- Beta-D-Glucopyranose Spirohydantoin
- (5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione
- alpha-D-glucose 6-phosphate
- N-beta-D-glucopyranosylacetamide
- Monofluorophosphate ion
- Beta-D-Glucose
- 3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
- Nojirimycine Tetrazole
- Indirubin-5-sulphonate
- 2-Deoxy-Glucose-6-Phosphate
- C-(1-hydrogyl-beta-D-glucopyranosyl) formamide
- alpha-D-glucopyranosyl-2-carboxylic acid amide
- alpha-D-glucose-1-phosphate
- 8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one
- 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole
- N-acetyl-N'-beta-D-glucopyranosyl urea
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole
- C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole
- CP-320626
- (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester
- 8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
- Alvocidib
- 1-deoxy-1-methoxycarbamido-beta-D-glucopyranose
- N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide
- 1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide
- 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
- 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium
- N(6)-(pyridoxal phosphate)-L-lysine
- Heptulose-2-Phosphate
- N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine
- Dexfosfoserine
- 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide
- Inosinic Acid
- 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID
- 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID
- 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID
- 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID
- 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL
- ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid
- (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol
- 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID
- (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
- (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
|
|
Diseases |
|
|
GWAS |
|
|
Interacting Genes |
31 interacting genes:
AGTPBP1
ARID1B
CDC42BPB
CLASP2
DNM2
ERO1B
FADS2
FAM110A
IGBP1
INTS4
LMNA
NIPSNAP2
NTAQ1
PDE4DIP
POMP
PPP1CA
PPP1R3B
PPP2CA
PRKAB2
PYGB
PYGL
S100A1
SGCG
SRP72
TOP1
TRAPPC2
TRIM54
TRIM55
TRIM63
TTN
WWP1
|
11 interacting genes:
ACTL6A
BRCA1
CNRIP1
ERP44
GNG4
HMGCS2
OGT
P4HB
PARVA
PYGM
TARBP1
|
Entrez ID |
5837 |
56605 |
HPRD ID |
01986 |
13279 |
Ensembl ID |
ENSG00000068976
|
ENSG00000086619
|
Uniprot IDs |
P11217
|
Q86YB8
|
PDB IDs |
1Z8D
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|